| Entry |
|
|---|
| Name |
Foscarnet sodium (USAN/INN);
Foscavir (TN)
|
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Other |
|
|---|
| Formula |
CO5P. 3Na
|
|---|
| Exact mass |
191.9176
|
|---|
| Mol weight |
191.9508
|
|---|
| Structure |
     |
|---|
| Activity |
|
|---|
| Remark |
|
|---|
| Target |
DNA polymerase inhibitor [EC: 2.7.7.7] |
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AD Phosphonic acid derivatives
J05AD01 Foscarnet
D00579 Foscarnet sodium (USAN/INN)
USP drug classification [BR:br08302]
Antivirals
Anti-cytomegalovirus (CMV) Agents
Foscarnet
D00579 Foscarnet sodium (USAN/INN)
Antiherpetic Agents
Foscarnet
D00579 Foscarnet sodium (USAN/INN)
Antiinfectives [BR:br08307]
Antivirals
Anti-CMV agent
DNA polymerase inhibitor
Phosphonic acid derivatives
Foscarnet [ATC:J05AD01]
D00579 Foscarnet sodium (USAN/INN)
 |
|---|
| Other DBs |
CAS: 63585-09-1 PubChem: DrugBank: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 10
1 Z Na 26.5842 -23.6738 #+
2 Z Na 30.8880 -22.3875 #+
3 Z Na 23.9722 -21.1394 #+
4 P1b P 27.2300 -21.1400
5 C6a C 28.6300 -21.1400
6 O1c O 27.2300 -22.5400 #-
7 O1c O 25.8300 -21.1400 #-
8 O1c O 27.2300 -19.7400
9 O6a O 29.3300 -22.4000 #-
10 O6a O 29.3300 -19.9500
BOND 6
1 4 6 1
2 4 7 1
3 4 8 2
4 5 9 1
5 4 5 1
6 5 10 2
|
|---|
